Tamim Shaikh
Concepts (364)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Abnormalities, Multiple | 14 | 2015 | 189 | 2.300 |
Why?
| | Chromosome Deletion | 16 | 2021 | 115 | 2.300 |
Why?
| | DNA Copy Number Variations | 9 | 2023 | 182 | 1.700 |
Why?
| | Chromosomes, Human, Pair 22 | 15 | 2019 | 45 | 1.440 |
Why?
| | Repetitive Sequences, Nucleic Acid | 12 | 2019 | 113 | 1.210 |
Why?
| | Craniofacial Abnormalities | 7 | 2021 | 72 | 1.150 |
Why?
| | Oligonucleotide Array Sequence Analysis | 18 | 2011 | 767 | 1.130 |
Why?
| | Gene Dosage | 12 | 2011 | 144 | 1.110 |
Why?
| | Gene Duplication | 7 | 2011 | 68 | 1.060 |
Why?
| | Vitamin B 12 | 3 | 2017 | 128 | 1.020 |
Why?
| | Host Cell Factor C1 | 3 | 2017 | 15 | 1.020 |
Why?
| | Segmental Duplications, Genomic | 3 | 2023 | 8 | 1.010 |
Why?
| | Chromosome Disorders | 3 | 2021 | 43 | 1.000 |
Why?
| | Heart Defects, Congenital | 4 | 2021 | 834 | 0.970 |
Why?
| | Intellectual Disability | 5 | 2021 | 165 | 0.960 |
Why?
| | Williams Syndrome | 2 | 2021 | 13 | 0.810 |
Why?
| | Translocation, Genetic | 12 | 2011 | 105 | 0.780 |
Why?
| | Chromosome Breakage | 10 | 2010 | 23 | 0.740 |
Why?
| | Genomic Structural Variation | 1 | 2021 | 12 | 0.710 |
Why?
| | Chromosome Mapping | 12 | 2023 | 524 | 0.700 |
Why?
| | Polymorphism, Single Nucleotide | 18 | 2015 | 2195 | 0.680 |
Why?
| | In Situ Hybridization, Fluorescence | 21 | 2019 | 317 | 0.640 |
Why?
| | Developmental Disabilities | 7 | 2021 | 265 | 0.640 |
Why?
| | Zebrafish | 4 | 2020 | 495 | 0.640 |
Why?
| | Gene Deletion | 6 | 2011 | 392 | 0.630 |
Why?
| | Repressor Proteins | 3 | 2017 | 427 | 0.590 |
Why?
| | Chromosome Aberrations | 7 | 2018 | 155 | 0.580 |
Why?
| | Mutation | 12 | 2021 | 3956 | 0.570 |
Why?
| | Vestibular Diseases | 2 | 2015 | 25 | 0.550 |
Why?
| | Genetic Diseases, X-Linked | 2 | 2017 | 24 | 0.550 |
Why?
| | Genetic Variation | 9 | 2016 | 988 | 0.550 |
Why?
| | Hematologic Diseases | 2 | 2015 | 62 | 0.550 |
Why?
| | Seizures | 1 | 2021 | 430 | 0.540 |
Why?
| | Chromosomes, Human, Pair 16 | 5 | 2021 | 36 | 0.490 |
Why?
| | Chromosomes, Human, Pair 1 | 4 | 2010 | 72 | 0.490 |
Why?
| | Histone Demethylases | 1 | 2015 | 32 | 0.470 |
Why?
| | Amino Acyl-tRNA Synthetases | 1 | 2015 | 30 | 0.470 |
Why?
| | Genome, Human | 6 | 2021 | 425 | 0.460 |
Why?
| | Chromosomes, Human, Pair 11 | 6 | 2003 | 59 | 0.450 |
Why?
| | Neoplasm Proteins | 2 | 2015 | 434 | 0.450 |
Why?
| | Face | 2 | 2015 | 173 | 0.440 |
Why?
| | Molecular Sequence Data | 22 | 2015 | 2904 | 0.440 |
Why?
| | Blepharophimosis | 1 | 2014 | 3 | 0.440 |
Why?
| | Skin Abnormalities | 1 | 2014 | 12 | 0.440 |
Why?
| | Frameshift Mutation | 1 | 2014 | 32 | 0.430 |
Why?
| | DNA-Binding Proteins | 5 | 2015 | 1501 | 0.430 |
Why?
| | Chromosomes, Human, Pair 6 | 2 | 2013 | 54 | 0.430 |
Why?
| | Brain Diseases | 1 | 2015 | 141 | 0.430 |
Why?
| | Genes, X-Linked | 1 | 2013 | 18 | 0.420 |
Why?
| | Codon, Nonsense | 1 | 2014 | 44 | 0.420 |
Why?
| | Hyperhomocysteinemia | 1 | 2013 | 27 | 0.420 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 1 | 2013 | 24 | 0.420 |
Why?
| | Syndrome | 10 | 2023 | 357 | 0.410 |
Why?
| | Histone Acetyltransferases | 1 | 2014 | 60 | 0.410 |
Why?
| | Base Sequence | 19 | 2017 | 2182 | 0.410 |
Why?
| | Zebrafish Proteins | 1 | 2014 | 287 | 0.360 |
Why?
| | Chromosomes, Human, Pair 13 | 2 | 2009 | 15 | 0.360 |
Why?
| | Autism Spectrum Disorder | 1 | 2016 | 396 | 0.360 |
Why?
| | Sequence Deletion | 5 | 2011 | 183 | 0.350 |
Why?
| | Chromosomes, Human, Pair 10 | 2 | 2011 | 19 | 0.350 |
Why?
| | Epilepsy | 1 | 2015 | 332 | 0.340 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2014 | 858 | 0.340 |
Why?
| | Chromosomes, Human, Pair 21 | 2 | 2011 | 44 | 0.340 |
Why?
| | Carrier Proteins | 1 | 2014 | 769 | 0.330 |
Why?
| | Nuclear Proteins | 1 | 2015 | 712 | 0.330 |
Why?
| | Genomics | 2 | 2023 | 792 | 0.330 |
Why?
| | Down Syndrome | 1 | 2016 | 491 | 0.330 |
Why?
| | Phenotype | 14 | 2021 | 3202 | 0.320 |
Why?
| | Humans | 74 | 2023 | 137294 | 0.320 |
Why?
| | Databases, Genetic | 2 | 2010 | 237 | 0.300 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2008 | 50 | 0.300 |
Why?
| | Infant | 19 | 2018 | 9451 | 0.300 |
Why?
| | DNA Mutational Analysis | 7 | 2015 | 400 | 0.300 |
Why?
| | Congenital Abnormalities | 1 | 2008 | 88 | 0.290 |
Why?
| | Child | 21 | 2021 | 21999 | 0.270 |
Why?
| | Autistic Disorder | 1 | 2010 | 204 | 0.270 |
Why?
| | Genome-Wide Association Study | 7 | 2021 | 1434 | 0.260 |
Why?
| | Genetic Predisposition to Disease | 7 | 2013 | 2419 | 0.250 |
Why?
| | Nondisjunction, Genetic | 2 | 2010 | 3 | 0.250 |
Why?
| | Branchial Region | 2 | 2017 | 36 | 0.250 |
Why?
| | Child, Preschool | 18 | 2021 | 11080 | 0.250 |
Why?
| | Gene Knockdown Techniques | 3 | 2020 | 327 | 0.240 |
Why?
| | Meiosis | 2 | 2010 | 81 | 0.240 |
Why?
| | Hyperglycinemia, Nonketotic | 2 | 2017 | 51 | 0.230 |
Why?
| | DiGeorge Syndrome | 4 | 2015 | 32 | 0.230 |
Why?
| | Amino Acid Sequence | 4 | 2020 | 2147 | 0.220 |
Why?
| | Primates | 5 | 2019 | 125 | 0.220 |
Why?
| | Rhabdoid Tumor | 4 | 2009 | 99 | 0.210 |
Why?
| | Gene Amplification | 4 | 2001 | 105 | 0.210 |
Why?
| | Polymerase Chain Reaction | 8 | 2011 | 1061 | 0.210 |
Why?
| | Sequence Alignment | 6 | 2015 | 345 | 0.200 |
Why?
| | Models, Genetic | 5 | 2011 | 607 | 0.190 |
Why?
| | Genetic Association Studies | 3 | 2020 | 377 | 0.180 |
Why?
| | Genetic Diseases, Inborn | 1 | 2001 | 42 | 0.180 |
Why?
| | Chromosome Breakpoints | 1 | 2021 | 8 | 0.180 |
Why?
| | Tanzania | 1 | 2021 | 58 | 0.180 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2021 | 56 | 0.180 |
Why?
| | Forkhead Transcription Factors | 2 | 2014 | 190 | 0.170 |
Why?
| | Transcription, Genetic | 2 | 2017 | 1456 | 0.170 |
Why?
| | DNA, Complementary | 2 | 1999 | 271 | 0.170 |
Why?
| | Male | 25 | 2021 | 67560 | 0.170 |
Why?
| | 22q11 Deletion Syndrome | 1 | 2019 | 2 | 0.160 |
Why?
| | Spasms, Infantile | 1 | 2021 | 122 | 0.160 |
Why?
| | Animals | 16 | 2020 | 36862 | 0.160 |
Why?
| | Karyotyping | 5 | 2018 | 105 | 0.160 |
Why?
| | Genotype | 8 | 2015 | 1923 | 0.160 |
Why?
| | Protein Subunits | 1 | 2020 | 239 | 0.150 |
Why?
| | Nucleic Acid Hybridization | 3 | 2007 | 190 | 0.150 |
Why?
| | Receptors, GABA-A | 1 | 2020 | 142 | 0.150 |
Why?
| | Prader-Willi Syndrome | 2 | 2013 | 27 | 0.150 |
Why?
| | Holoprosencephaly | 1 | 2018 | 8 | 0.150 |
Why?
| | Cell Cycle Proteins | 2 | 1999 | 613 | 0.140 |
Why?
| | Cell Differentiation | 2 | 2017 | 1987 | 0.140 |
Why?
| | Sequence Homology, Nucleic Acid | 6 | 2008 | 154 | 0.140 |
Why?
| | RNA Polymerase III | 1 | 1997 | 28 | 0.140 |
Why?
| | AT Rich Sequence | 3 | 2010 | 4 | 0.140 |
Why?
| | Chromosomal Proteins, Non-Histone | 2 | 2009 | 126 | 0.140 |
Why?
| | Methylmalonic Acid | 1 | 2017 | 65 | 0.130 |
Why?
| | Primary Cell Culture | 1 | 2017 | 171 | 0.130 |
Why?
| | Gene Expression Regulation | 3 | 2017 | 2608 | 0.130 |
Why?
| | Sequence Analysis, DNA | 5 | 2011 | 812 | 0.130 |
Why?
| | Vitamin B 12 Deficiency | 1 | 2017 | 81 | 0.130 |
Why?
| | Polymorphism, Genetic | 4 | 2005 | 658 | 0.130 |
Why?
| | Cohort Studies | 2 | 2021 | 5726 | 0.130 |
Why?
| | Glycine | 1 | 2017 | 175 | 0.120 |
Why?
| | Glucose Transporter Type 3 | 1 | 2015 | 13 | 0.120 |
Why?
| | Aminoacylation | 1 | 2015 | 14 | 0.120 |
Why?
| | DNA Probes | 2 | 2008 | 60 | 0.120 |
Why?
| | Chromosomal Instability | 2 | 2019 | 19 | 0.120 |
Why?
| | Motor Activity | 1 | 2020 | 719 | 0.120 |
Why?
| | Gene Expression | 1 | 2020 | 1501 | 0.110 |
Why?
| | Heterozygote | 5 | 2020 | 292 | 0.110 |
Why?
| | Female | 21 | 2021 | 73052 | 0.110 |
Why?
| | Forkhead Box Protein L2 | 1 | 2014 | 3 | 0.110 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 2 | 2013 | 242 | 0.110 |
Why?
| | Oxidoreductases | 1 | 2014 | 94 | 0.110 |
Why?
| | Sulfurtransferases | 1 | 2013 | 10 | 0.110 |
Why?
| | Glutaredoxins | 1 | 2013 | 13 | 0.110 |
Why?
| | RNA, Transfer | 1 | 2015 | 138 | 0.110 |
Why?
| | Exome | 1 | 2015 | 231 | 0.110 |
Why?
| | Body Patterning | 1 | 2014 | 132 | 0.110 |
Why?
| | Neural Crest | 1 | 2014 | 116 | 0.110 |
Why?
| | Inverted Repeat Sequences | 2 | 2010 | 20 | 0.100 |
Why?
| | Urogenital Abnormalities | 1 | 2014 | 64 | 0.100 |
Why?
| | Green Fluorescent Proteins | 1 | 2014 | 390 | 0.100 |
Why?
| | Hypothyroidism | 1 | 2013 | 72 | 0.100 |
Why?
| | Comparative Genomic Hybridization | 4 | 2018 | 30 | 0.100 |
Why?
| | Elastin | 1 | 2013 | 78 | 0.100 |
Why?
| | Infant, Newborn | 4 | 2017 | 6054 | 0.100 |
Why?
| | Mosaicism | 2 | 2010 | 73 | 0.100 |
Why?
| | Microarray Analysis | 2 | 2010 | 116 | 0.100 |
Why?
| | Chondrocytes | 1 | 2014 | 213 | 0.100 |
Why?
| | Nucleic Acid Amplification Techniques | 2 | 2009 | 37 | 0.100 |
Why?
| | Fibroblasts | 1 | 2017 | 993 | 0.090 |
Why?
| | Mental Disorders | 1 | 2021 | 1077 | 0.090 |
Why?
| | Vesicular Acetylcholine Transport Proteins | 1 | 2011 | 4 | 0.090 |
Why?
| | Proteins | 2 | 2013 | 1012 | 0.090 |
Why?
| | Philadelphia | 1 | 2011 | 49 | 0.090 |
Why?
| | Age of Onset | 1 | 2013 | 519 | 0.090 |
Why?
| | Nerve Growth Factors | 1 | 2011 | 79 | 0.090 |
Why?
| | Alleles | 4 | 2020 | 892 | 0.090 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 622 | 0.090 |
Why?
| | HEK293 Cells | 1 | 2013 | 731 | 0.090 |
Why?
| | Alu Elements | 2 | 2000 | 28 | 0.090 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2011 | 62 | 0.090 |
Why?
| | Chromosomes, Human, Pair 8 | 1 | 2010 | 36 | 0.080 |
Why?
| | Cloning, Molecular | 3 | 2005 | 536 | 0.080 |
Why?
| | Binding Sites | 1 | 2013 | 1309 | 0.080 |
Why?
| | Stem Cells | 1 | 2014 | 593 | 0.080 |
Why?
| | Cell Movement | 1 | 2014 | 969 | 0.080 |
Why?
| | Transcription Factors | 2 | 2009 | 1720 | 0.080 |
Why?
| | Base Pairing | 1 | 2009 | 63 | 0.080 |
Why?
| | Chromosomes, Human, Pair 20 | 1 | 2009 | 17 | 0.080 |
Why?
| | Mice, Transgenic | 1 | 2014 | 2164 | 0.080 |
Why?
| | Blindness, Cortical | 1 | 2008 | 5 | 0.080 |
Why?
| | Chromosomes, Human, Pair 7 | 1 | 2008 | 18 | 0.080 |
Why?
| | DNA, Circular | 1 | 2008 | 15 | 0.080 |
Why?
| | Evolution, Molecular | 2 | 2019 | 488 | 0.070 |
Why?
| | Hematologic Neoplasms | 1 | 2011 | 155 | 0.070 |
Why?
| | Synaptic Transmission | 1 | 2011 | 289 | 0.070 |
Why?
| | DNA Primers | 5 | 2003 | 514 | 0.070 |
Why?
| | Cleft Lip | 1 | 2008 | 51 | 0.070 |
Why?
| | Gene Silencing | 1 | 2009 | 195 | 0.070 |
Why?
| | Molecular Probe Techniques | 1 | 2008 | 10 | 0.070 |
Why?
| | Brain | 3 | 2017 | 2675 | 0.070 |
Why?
| | Haploinsufficiency | 3 | 2013 | 56 | 0.070 |
Why?
| | Neuroblastoma | 1 | 2009 | 160 | 0.070 |
Why?
| | RNA, Messenger | 2 | 2013 | 2839 | 0.070 |
Why?
| | Beckwith-Wiedemann Syndrome | 1 | 2007 | 6 | 0.070 |
Why?
| | Astrocytoma | 1 | 2008 | 128 | 0.070 |
Why?
| | Hernia, Diaphragmatic | 1 | 2007 | 65 | 0.070 |
Why?
| | Central Nervous System | 1 | 2009 | 258 | 0.070 |
Why?
| | DNA | 4 | 2010 | 1459 | 0.070 |
Why?
| | Protein Binding | 1 | 2013 | 2225 | 0.070 |
Why?
| | Synapses | 1 | 2011 | 427 | 0.070 |
Why?
| | Nerve Tissue Proteins | 1 | 2011 | 596 | 0.070 |
Why?
| | Cleft Palate | 1 | 2007 | 67 | 0.070 |
Why?
| | Gene Frequency | 4 | 2013 | 521 | 0.070 |
Why?
| | Learning | 1 | 2010 | 415 | 0.060 |
Why?
| | Young Adult | 3 | 2018 | 13163 | 0.060 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2008 | 215 | 0.060 |
Why?
| | Pulmonary Alveoli | 1 | 2009 | 405 | 0.060 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2008 | 226 | 0.060 |
Why?
| | Teratoma | 1 | 2007 | 114 | 0.060 |
Why?
| | Genes, Neurofibromatosis 1 | 1 | 2005 | 4 | 0.060 |
Why?
| | Research Design | 2 | 2009 | 1128 | 0.060 |
Why?
| | Chromosomes, Human, Pair 18 | 1 | 2005 | 10 | 0.060 |
Why?
| | Schizophrenia | 1 | 2009 | 439 | 0.060 |
Why?
| | Nucleic Acid Conformation | 1 | 2008 | 730 | 0.060 |
Why?
| | Computational Biology | 1 | 2010 | 646 | 0.060 |
Why?
| | Conserved Sequence | 1 | 2005 | 240 | 0.060 |
Why?
| | Adult | 8 | 2015 | 37724 | 0.060 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 422 | 0.060 |
Why?
| | Trisomy | 1 | 2005 | 82 | 0.060 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1774 | 0.060 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2009 | 382 | 0.050 |
Why?
| | Biological Evolution | 4 | 1996 | 465 | 0.050 |
Why?
| | Chromosome Fragile Sites | 1 | 2003 | 1 | 0.050 |
Why?
| | Chromosomes, Human, 21-22 and Y | 1 | 2003 | 3 | 0.050 |
Why?
| | Chromosomes, Human, Pair 4 | 1 | 2003 | 30 | 0.050 |
Why?
| | Mice, Knockout | 1 | 2010 | 3009 | 0.050 |
Why?
| | Genetic Testing | 2 | 2011 | 454 | 0.050 |
Why?
| | Dinucleotide Repeats | 1 | 2003 | 5 | 0.050 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2003 | 55 | 0.050 |
Why?
| | DNA Transposable Elements | 2 | 1995 | 123 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 976 | 0.050 |
Why?
| | Cell Line | 4 | 2019 | 2841 | 0.050 |
Why?
| | Adolescent | 8 | 2018 | 21499 | 0.050 |
Why?
| | Consensus Sequence | 3 | 1997 | 73 | 0.050 |
Why?
| | Hereditary Sensory and Motor Neuropathy | 1 | 2001 | 1 | 0.050 |
Why?
| | Mice | 4 | 2011 | 17774 | 0.050 |
Why?
| | Angelman Syndrome | 1 | 2001 | 11 | 0.050 |
Why?
| | Chromosomes, Human | 1 | 2001 | 44 | 0.050 |
Why?
| | Genetic Markers | 2 | 1999 | 344 | 0.050 |
Why?
| | Charcot-Marie-Tooth Disease | 1 | 2001 | 21 | 0.050 |
Why?
| | Haplotypes | 1 | 2023 | 493 | 0.050 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2021 | 142 | 0.040 |
Why?
| | Recombination, Genetic | 1 | 2001 | 199 | 0.040 |
Why?
| | Pan paniscus | 1 | 2000 | 4 | 0.040 |
Why?
| | Contig Mapping | 1 | 2000 | 11 | 0.040 |
Why?
| | Disease Models, Animal | 1 | 2010 | 4284 | 0.040 |
Why?
| | Artifacts | 1 | 2000 | 129 | 0.040 |
Why?
| | Physical Chromosome Mapping | 1 | 1999 | 20 | 0.040 |
Why?
| | Gorilla gorilla | 1 | 2000 | 23 | 0.040 |
Why?
| | Time Factors | 2 | 2008 | 6818 | 0.040 |
Why?
| | HeLa Cells | 2 | 2000 | 637 | 0.040 |
Why?
| | Tumor Cells, Cultured | 2 | 2000 | 954 | 0.040 |
Why?
| | Macaca mulatta | 1 | 2000 | 168 | 0.040 |
Why?
| | Enhancer Elements, Genetic | 1 | 2000 | 190 | 0.040 |
Why?
| | Follow-Up Studies | 1 | 2008 | 5125 | 0.040 |
Why?
| | Brain Neoplasms | 1 | 2008 | 1242 | 0.040 |
Why?
| | Locomotion | 1 | 2020 | 106 | 0.040 |
Why?
| | Larva | 1 | 2020 | 222 | 0.040 |
Why?
| | Phylogeny | 2 | 2001 | 900 | 0.040 |
Why?
| | Family Health | 1 | 1999 | 197 | 0.040 |
Why?
| | Cytogenetics | 1 | 2018 | 10 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1999 | 387 | 0.040 |
Why?
| | Cosmids | 1 | 1997 | 5 | 0.040 |
Why?
| | SMARCB1 Protein | 2 | 2009 | 31 | 0.040 |
Why?
| | Chromosomes, Artificial, Bacterial | 2 | 2010 | 19 | 0.040 |
Why?
| | Carcinoma, Embryonal | 1 | 1997 | 3 | 0.040 |
Why?
| | DNA Replication | 1 | 1999 | 238 | 0.030 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1997 | 143 | 0.030 |
Why?
| | Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1997 | 73 | 0.030 |
Why?
| | Cytoplasm | 1 | 1997 | 272 | 0.030 |
Why?
| | Random Allocation | 1 | 1997 | 353 | 0.030 |
Why?
| | Cardiovascular Diseases | 1 | 2008 | 2113 | 0.030 |
Why?
| | Cells, Cultured | 3 | 2011 | 4197 | 0.030 |
Why?
| | Recurrence | 2 | 2010 | 1059 | 0.030 |
Why?
| | Pedigree | 2 | 2010 | 514 | 0.030 |
Why?
| | Plasmids | 2 | 2008 | 362 | 0.030 |
Why?
| | Cell Nucleus | 1 | 1997 | 617 | 0.030 |
Why?
| | Hominidae | 1 | 1994 | 85 | 0.030 |
Why?
| | RNA | 1 | 2000 | 924 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2013 | 2836 | 0.030 |
Why?
| | Endocrine System | 1 | 2013 | 20 | 0.030 |
Why?
| | Aortic Stenosis, Supravalvular | 1 | 2013 | 4 | 0.030 |
Why?
| | Atrophy | 1 | 2013 | 184 | 0.030 |
Why?
| | Chromosome Banding | 2 | 2005 | 19 | 0.030 |
Why?
| | Fatal Outcome | 1 | 2013 | 305 | 0.030 |
Why?
| | Case-Control Studies | 2 | 2011 | 3546 | 0.020 |
Why?
| | Aorta, Thoracic | 1 | 2015 | 267 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 1484 | 0.020 |
Why?
| | Prognosis | 2 | 2011 | 4026 | 0.020 |
Why?
| | Penetrance | 1 | 2011 | 28 | 0.020 |
Why?
| | Homologous Recombination | 1 | 2011 | 26 | 0.020 |
Why?
| | Gene Order | 1 | 2011 | 26 | 0.020 |
Why?
| | Mitochondrial Proteins | 1 | 2013 | 256 | 0.020 |
Why?
| | T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2011 | 1 | 0.020 |
Why?
| | Sclerosis | 1 | 2011 | 13 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-bcl-6 | 1 | 2011 | 8 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2011 | 16 | 0.020 |
Why?
| | Collagen Type VI | 1 | 2011 | 6 | 0.020 |
Why?
| | Monosomy | 1 | 2010 | 12 | 0.020 |
Why?
| | Genotyping Techniques | 1 | 2011 | 75 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2011 | 69 | 0.020 |
Why?
| | Muscular Dystrophies | 1 | 2011 | 36 | 0.020 |
Why?
| | Spermatogenesis | 1 | 2010 | 67 | 0.020 |
Why?
| | Health | 1 | 2010 | 84 | 0.020 |
Why?
| | Gene Rearrangement | 1 | 2010 | 149 | 0.020 |
Why?
| | Spermatozoa | 1 | 2010 | 94 | 0.020 |
Why?
| | Receptor, Metabotropic Glutamate 5 | 1 | 2009 | 5 | 0.020 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2009 | 10 | 0.020 |
Why?
| | Serrate-Jagged Proteins | 1 | 2009 | 27 | 0.020 |
Why?
| | Jagged-1 Protein | 1 | 2009 | 23 | 0.020 |
Why?
| | Loss of Heterozygosity | 1 | 2009 | 51 | 0.020 |
Why?
| | Receptors, Metabotropic Glutamate | 1 | 2009 | 40 | 0.020 |
Why?
| | Alagille Syndrome | 1 | 2009 | 33 | 0.020 |
Why?
| | Ultrasonography | 1 | 2013 | 752 | 0.020 |
Why?
| | Genes, Tumor Suppressor | 1 | 2009 | 86 | 0.020 |
Why?
| | Capillaries | 1 | 2009 | 108 | 0.020 |
Why?
| | Concept Formation | 1 | 2008 | 32 | 0.020 |
Why?
| | Population Groups | 1 | 2008 | 62 | 0.020 |
Why?
| | Coloboma | 1 | 2008 | 5 | 0.020 |
Why?
| | Quality Control | 1 | 2008 | 171 | 0.020 |
Why?
| | Hybrid Cells | 2 | 2000 | 49 | 0.020 |
Why?
| | Pulmonary Veins | 1 | 2009 | 99 | 0.020 |
Why?
| | Calcium-Binding Proteins | 1 | 2009 | 218 | 0.020 |
Why?
| | Models, Biological | 2 | 2008 | 1773 | 0.020 |
Why?
| | Doxorubicin | 1 | 2009 | 365 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 1 | 2011 | 647 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2009 | 382 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2008 | 321 | 0.020 |
Why?
| | DNA, Cruciform | 1 | 2005 | 4 | 0.020 |
Why?
| | Blotting, Western | 1 | 2008 | 1226 | 0.020 |
Why?
| | Family | 1 | 2010 | 666 | 0.010 |
Why?
| | COS Cells | 1 | 2005 | 188 | 0.010 |
Why?
| | Biomarkers | 1 | 2017 | 4164 | 0.010 |
Why?
| | Genomic Instability | 1 | 2005 | 53 | 0.010 |
Why?
| | Fetus | 1 | 2009 | 806 | 0.010 |
Why?
| | Primed In Situ Labeling | 1 | 2003 | 1 | 0.010 |
Why?
| | Neurofibromin 1 | 1 | 2003 | 26 | 0.010 |
Why?
| | Centromere | 1 | 2003 | 59 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2009 | 1163 | 0.010 |
Why?
| | Algorithms | 1 | 2010 | 1692 | 0.010 |
Why?
| | Introns | 1 | 2003 | 256 | 0.010 |
Why?
| | Exons | 1 | 2003 | 351 | 0.010 |
Why?
| | Lymphocytes | 1 | 2003 | 395 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2009 | 3283 | 0.010 |
Why?
| | DNA, Recombinant | 1 | 2000 | 47 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2000 | 200 | 0.010 |
Why?
| | Chromosome Fragility | 1 | 2000 | 2 | 0.010 |
Why?
| | 3T3 Cells | 1 | 2000 | 163 | 0.010 |
Why?
| | Mutagenesis | 1 | 2000 | 182 | 0.010 |
Why?
| | Obesity | 1 | 2013 | 2983 | 0.010 |
Why?
| | Telomere | 1 | 2003 | 280 | 0.010 |
Why?
| | RNA Stability | 1 | 2000 | 117 | 0.010 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 1999 | 45 | 0.010 |
Why?
| | Prospective Studies | 1 | 2011 | 7595 | 0.010 |
Why?
| | Sequence Tagged Sites | 1 | 1997 | 5 | 0.010 |
Why?
| | Chromosomes, Artificial, Yeast | 1 | 1997 | 4 | 0.010 |
Why?
| | Chromosomes, Bacterial | 1 | 1997 | 9 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2007 | 2679 | 0.010 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 1999 | 455 | 0.010 |
Why?
| | Bacteriophages | 1 | 1997 | 95 | 0.010 |
Why?
| | Sequence Analysis | 1 | 1995 | 36 | 0.010 |
Why?
| | Risk Factors | 1 | 2009 | 10368 | 0.010 |
Why?
| | Mutagenesis, Insertional | 1 | 1995 | 65 | 0.010 |
Why?
| | Rodentia | 1 | 1995 | 56 | 0.010 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 1994 | 68 | 0.010 |
Why?
| | Africa | 1 | 1994 | 108 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2007 | 10800 | 0.010 |
Why?
| | Middle Aged | 1 | 2013 | 33310 | 0.010 |
Why?
| | Species Specificity | 1 | 1990 | 585 | 0.000 |
Why?
|
|
Shaikh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|